New devices for asthma

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 2 SUPPL., 1998, Pages

  Tashkin, Donald P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN HYDROGEN TARTRATE; ANTIASTHMATIC AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHLOROFLUOROCARBON; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUORINATED HYDROCARBON; ISOPRENALINE; PROPELLANT; SALBUTAMOL; TERBUTALINE;

ASTHMA; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; NEBULIZER; POWDER INHALER; PRIORITY JOURNAL;

ASTHMA; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS;

EID: 0031945816     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70233-7     Document Type: Article

References (25)

1. Grossman J. The evolution of inhaler technology. J Asthma 1994;31:55-64.
2. Hess D, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance: effects of diluent volume, nebulizer flow and nebulizer brand. Chest 1996;110:498-505.
3. Tashkin DP. Dosing strategies for aerosol delivery to the airways. Respir Care 1991;36:977-88.
4. Newman SP, Pavia D, Clarke SW. How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis 1981;62:3-20.
5. Newman SP. Aerosol generators and delivery systems. Respir Care 1991;36:939-51.
6. Hayman G. Why the environment matters. Br J Clin Pract 1995;79:2-6.
7. Tashkin D. Cumulative dose-response study of Airomir (salbutamol sulphate in CFC-free system) versus CFC salbutamol in patients with asthma. Br J Clin Pract 1995;79:33-4.
8. Newman SP, Moren F, Trofast E, Talaee N, Clarke SW. Terbutaline sulphate Turbuhaler effect of inhaled flow rate on drug deposition and efficacy. Int J Pharmaceutics 1991;74:209-13.
9. Thorsson L, Edsbacker S, Conradson T-B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 1994;7:1839-44.
10. Hill M, Vaughan L, Dolovich M. Characteristics of an active, multiple-dose, dry powder inhaler. In: Bryon PR, Dolby RN, Farr SJ, editors. Respiratory drug delivery V. Buffalo Grove, Ill: Interpharm Press, Inc; 1996. p. 197-208.
11. Newman SP, Weisz AWB, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique. Thorax 1991;46:712-6.
12. Crompton G, Duncan J. Clinical assessment of a new breath-actuated inhaler. Practitioner 1989;233:268-9.
13. Fergusson RJ, Lenney J, McHardy GJR, Crompton GK. The use of a new breath-actuated inhaler by patients with severe airflow obstruction. Eur Respir J 1991;4:172-4.
14. Arthur V, Pushkin S, Emery P. Inhaler use in patients with arthritic hands. Clin Trials Meta-Anal 1992;28:23-8.
15. Diggory P, Bailey R, Vallon A. Effectiveness of inhaled bronchodilator delivery systems for elderly patients. Age Aging 1991;20:379-82.
16. Benton G, Thomas RC, Nickerson BG, McQuity JC, Okikawa J. Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. Am J Dis Child 1989;143:678-81.
17. Bisgaard H, Anhoj J, Klug B, Berg E. A non-electrostatic spacer for aerosol delivery. Arch Dis Child 1995;73:226-30.
18. Agertoft L, Pedersen S. Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994;71:217-20.
19. O'Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, avoiding multiple actuations of drug. Thorax 1993;48:603-6.
20. Barry PW, O'Callaghan C. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Eur Respir J 1994;7:1707-9.
21. Ahrens R, Lux C, Bahl T, Han S-H. Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration. J Allergy Clin Immunol 1995;96:288-94.
22. Tashkin DP. Multiple dose regimens: impact on compliance. Chest 1995;107:176S-82S.
23. Rand CS, Wise RA, Nides M, Simmons MS, Bleeker ER, Kusch JW, et al. Inhaler adherence in a clinical trial: comparison of self-report and canister weighing to the nebulizer chronolog. Am Rev Respir Dis 1992;146:1559-64.
24. Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993;104:501-7.
25. Farr SJ, Rowe A, Rubsamen R, Tayler G. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurized metered dose inhaler. Thorax 1995;50:639-44.